Integration of patient-reported outcomes into survivorship care.

Authors

null

Katherine Ramsey Gilmore

Office of Cancer Survivorship, The University of Texas MD Anderson Cancer Center, Houston, TX

Katherine Ramsey Gilmore, Patricia Hansberry Chapman, Johnny Rollins, Soo Lee-Kim, Justine Robinson, Ellen Mullen, Haleigh Mistry, Prachee Singh, Robin Coyne, Ana Nelson, William Osai, Karen Stolar, Susan Knippel, Danielle M. Fournier, Tamera Plair, Angela Peek, Maria Alma Rodriguez

Organizations

Office of Cancer Survivorship, The University of Texas MD Anderson Cancer Center, Houston, TX, MD Anderson Cancer Center, Houston, TX, Endocrine Neoplasia and Hormonal Disorders Department, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, The University of Texas MD Anderson Cancer Center, Department of Lymphoma/Myeloma, Houston, TX, University of Texas MD Anderson Cancer Center, Houston, TX, Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Funding

No funding received
None.

Background: Patient reported outcomes (PRO) can be valuable clinical tools to embed the voice of patients into the clinical experience. The use of PROs in the context of cancer survivorship is relatively under-explored. Methods: Disease-specific modules of the MD Anderson Symptom Inventory (MDASI) PRO were integrated into the electronic health record (EHR), and distributed 3-7 days prior to survivorship clinic visits through the patients’ EHR portal. Patients with virtual visits were called 24 hours prior, instructed how to video link, and how to complete the MDASI PRO. For patients who completed the PRO electronically, results were reviewed during clinic visit. High symptom alerts (> = 7) for four key symptoms were established and triggered an automatic message to care teams for review. Results: From Sept 1, 2020 – August 31, 2021, 2,196 PRO surveys were sent to patients with 1,268 submitting results (57.74%) (see Table). Within specific clinics, the submission rates varied greatly between in-person and virtual appointments (33% vs. 83%). Submission rates varied by clinics, with responses ranging from 28.57% - 73.59%. Clinics with higher overall rates had a higher proportion of virtual visits. Conclusions: Electronic distribution of PROs can be successfully integrated into long term survivorship clinic visits. Virtual visits had overall much higher PRO response rates, due to pre-visit workflows which encouraged the completion of PROs. We conclude that patient education and real time support is needed to facilitate patients’ completion of PRO surveys through the electronic portal.

Patient reported outcomes submission rates by clinic (Sept 1, 2020 – August 31, 2021).

Clinic
# Submitted - Virtual Appt
# Sent - Virtual Appt
% Submitted - Virtual Appt
# Submitted - In Person Appt
# Sent - In Person Appt
% Submitted - In Person Appt
Total % Submitted - All Appt
Breast
0
0
N/A
23
82
28.05%
28.05%
GU
185
267
69.29%
11
39
28.21%
64.05%
Head & Neck
107
116
92.24%
128
477
26.83%
39.63%
Lymphoma
0
0
N/A
24
73
32.88%
32.88%
Stem cell transplant
6
13
46.15%
52
130
40.00%
40.56%
Thoracic
1
1
100.00%
1
6
16.67%
28.57%
Thyroid
600
681
88.11%
130
311
41.80%
73.59%
Grand Total
899
1078
83.40%
369
1118
33.01%
57.74%

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2022 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience

Sub Track

Integrating Patient Experience Assessment and Patient Reported Outcomes Into Practice

Citation

J Clin Oncol 40, 2022 (suppl 28; abstr 271)

DOI

10.1200/JCO.2022.40.28_suppl.271

Abstract #

271

Poster Bd #

G10

Abstract Disclosures

Similar Abstracts

First Author: Laura LaNiel Tenner

First Author: Stephanie M Smith

Abstract

2022 ASCO Quality Care Symposium

Shift in survivorship care delivery.

First Author: Elizabeth Boutin McGrath

First Author: Renee Gilbert